Category: AtriCure Inc.Syndicate content

AtriCure's Q4 prelims send shares up

January 10, 2014 by Brad Perriello

AtriCure's report of strong sales growth for the 4th quarter and 2013 sends share prices up on Wall Street.

AtriCure's Q4 prelims send shares up

Fresh off of the $34 million acquisition of Estech, AtriCure (NSDQ:ATRC) reported strong sales growth for the 4th quarter and 2013 and predicted even better gains for this year, sending share prices up today on Wall Street.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

AtriCure acquires Estech's ablation systems in $34M deal

January 3, 2014 by Chris Walker

AtriCure offers $34 million up-front in stock for surgical ablation devices maker Estech, with another $26 million tied to performance-based milestones.

AtriCure acquires Estech in $34M deal

AtriCure (NSDQ:ATRC) signed a definitive agreement with Estech, offering to give the ablation devices maker about $34 million in stock.

AtriCure wins FDA nod for anti-stroke device trial

November 19, 2013 by Brad Perriello

AtriCure says the FDA granted an investigational device exemption for a clinical trial of its AtriClip left atrial appendage exclusion device to gauge its utility in preventing stroke in patients with atrial fibrillation.

AtriCure wins FDA nod for anti-stroke device trial

AtriCure (NSDQ:ATRC) said today that the FDA approved the launch of a clinical trial to examine whether its AtriClip device can be used to prevent strokes in patients with atrial fibrillation.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

AtriCure gains on surging Q3 sales, raised outlook

October 30, 2013 by Brad Perriello

AtriCure shares are up today after the medical device company reported surging 3rd-quarter sales and raised its outlook for the rest of the year.

AtriCure gains on surging Q3 sales, raised outlook

AtriCure (NSDQ:ATRC) shares added more than 8% today after the medical device company reported 3r-quarter sales that beat Wall Street's forecast and raised its outlook for the rest of the year.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

AtriCure vows to reach 250k patients by 2020

September 19, 2013 by Arezu Sarvestani

Ohio medical device maker AtriCure pledges to make "significant investments" into research and education in efforts to improve the lives of 250,000 atrial fibrillation patients by 2020.

AtriCure vows to help 250k afib patients with Synergy ablation

AtriCure widens exclusive contract with Japanese distributor

August 29, 2013 by Sony Salzman

AtriCure and Century Medical beef up their Japanese distribution contract for surgical ablation tools, extending exclusivity until 2019.

AtriCure and Century Medical expand partnership

AtriCure (NSDQ:ATRC) inked a bigger and bolder contract with its Japanese distributor Century Medical Inc., promising its partner exclusive rights for all product lines until 2019.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp